PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Combination of W. coagulans and Fagonia cretica crude extracts ameliorated hyperuricemia in mice models [PMID:40712280]
Aqueous fruit extract (1000mg/kg) significantly reduced fasting blood glucose levels in diabetic rats [PMID:23105813]; methanolic extracts also showed hypoglycemic effects in rabbits [PMID:40510951]
Coagulin-L alleviated hepatic stellate cells activation and angiogenesis in MCD diet-induced liver fibrosis mice models [PMID:40345560]
Coagulansin-A (10mg/kg i.p.) improved body weight and antioxidant potential in CFA-induced arthritic mice [PMID:38908719]
Fruit extract demonstrated gastroprotective effects against acidified ethanol-induced ulcers in rats [PMID:40636368]
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 12770585 (2003) — Withanolides from Withania coagulans. · Phytochemistry
- 2.PMID: 19774603 (2009) — Immunosuppressive withanolides from Withania coagulans. · Chemistry & biodiversity
- 3.PMID: 40712280 (2025) — Combination of Withania coagulans and Fagonia cretica ameliorates hyperuricemia by re-modulating gut microbiota-derived spermidine and traumatic acid. · Phytomedicine : international journal of phytotherapy and phytopharmacology
- 4.PMID: 40345560 (2025) — Coagulin-L alleviates hepatic stellate cells activation and angiogenesis through modulation of the PI3K/AKT pathway during liver fibrosis. · Biochemical pharmacology
- 5.PMID: 40720462 (2025) — Prevalence of multidrug-resistant biofilm-forming pathogens in diabetic foot ulcers and antimicrobial activity of nanoparticles.